Recent studies have shown that genetic reduction of STEP improves cognition, synaptic plasticity, and NMDA receptor subunit expression in mouse models of Alzheimer’s disease [78] and reduced seizures, anti-social, and anxiety-related behaviors in Fmr1 KO mice [73]. This evidence concerns the gene FMR1 and early-onset autosomal dominant Alzheimer disease.